News
Transgender care: BMA adopts neutral position on Cass review after backlash from members
BMJ 2024; 386 doi: https://doi.org/10.1136/bmj.q2137 (Published 30 September 2024) Cite this as: BMJ 2024;386:q2137- Ingrid Torjesen
- London
The BMA has retracted its call for the UK government to lift the ban on prescribing puberty blockers to under 18s with gender dysphoria while the association conducts an evaluation of the Cass review’s recommendations.
After pressure from members and from other doctors and clinicians the BMA has confirmed that it will now take a neutral position on the recommendations while it carries out its evaluation.
The BMA called for the ban on the use of puberty blockers to be lifted on 31 July after the …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.